Clifford J. “Cliff” Stocks and his wife Renée Riggan-Stocks are selling their palatial French/Georgian style manse in Clyde Hill, listing it at $10.28 million. They plan to downsize, as three of their five children are almost grown and gone.
Clifford Stocks is founder and CEO of OncoResponse Inc., a Seattle-based, venture-backed biotech company which is focused on immuno-oncology, and developing a more universal, widespread response to immunotherapy.
